Termination Letter for Equity Distribution Agreement between Hemispherx Biopharma, Inc. and Maxim Group LLC
Hemispherx Biopharma, Inc. and Maxim Group LLC have agreed to end their Equity Distribution Agreement, originally dated July 23, 2012, and later amended. The termination is effective as of July 17, 2019. This letter serves as formal notice that the agreement is no longer in effect, with no further obligations between the parties under the terminated agreement.
Exhibit 10.1
Hemispherx Biopharma, Inc.
2117 SW Highway 484
Ocala, FL 34473
| July 17, 2019 |
Maxim Group LLC
405 Lexington Avenue
New York, New York 10174
Re: Termination of Equity Distribution Agreement by and between Hemispherx Biopharma, Inc. (the “Company”) and Maxim Group LLC (“Maxim”) dated July 23, 2012, as subsequently amended (the “EDA”)
Dear Sir or Madam:
Pursuant to our discussions we have agreed to terminate the EDA. Accordingly, pursuant to Section 7(a) of the EDA, the Company hereby terminates the EDA, effective as of the close of business today, July 17, 2019.
| Sincerely, | |
| /s/ Thomas K. Equels | |
| Thomas K. Equels, CEO |
